Literature DB >> 27529392

Antipsychotic-induced akathisia in cancer settings.

Fernando Espi Forcen1, James C Root2, Yesne Alici2.   

Abstract

Entities:  

Year:  2016        PMID： 27529392      PMCID： PMC5654573          DOI： 10.1002/pon.4247

Source DB:  PubMed          Journal:  Psychooncology        ISSN： 1057-9249            Impact factor:   3.894


× No keyword cloud information.
  7 in total

Review 1.  First do no harm... Terminal restlessness or drug-induced delirium.

Authors:  Clare White; Mary Ann McCann; Neil Jackson
Journal:  J Palliat Med       Date:  2007-04       Impact factor: 2.947

2.  Akathisia variants and tardive dyskinesia.

Authors:  T R Barnes; W M Braude
Journal:  Arch Gen Psychiatry       Date:  1985-09

Review 3.  Antipsychotic-induced akathisia in delirium: A systematic review.

Authors:  Fernando Espi Forcen; Konstantina Matsoukas; Yesne Alici
Journal:  Palliat Support Care       Date:  2015-06-19

4.  Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial.

Authors:  Timothy D Girard; Pratik P Pandharipande; Shannon S Carson; Gregory A Schmidt; Patrick E Wright; Angelo E Canonico; Brenda T Pun; Jennifer L Thompson; Ayumi K Shintani; Herbert Y Meltzer; Gordon R Bernard; Robert S Dittus; E Wesley Ely
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

Review 5.  The present status of akathisia.

Authors:  P Sachdev; C Longragan
Journal:  J Nerv Ment Dis       Date:  1991-07       Impact factor: 2.254

6.  Unexpectedly high prevalence of akathisia in cancer patients.

Authors:  Chiaki Kawanishi; Hideki Onishi; Daiji Kato; Ikuko Kishida; Taku Furuno; Makoto Wada; Yoshio Hirayasu
Journal:  Palliat Support Care       Date:  2007-12

7.  Pharmacovigilance in hospice/palliative care: net effect of haloperidol for delirium.

Authors:  Gregory B Crawford; Meera Agar M; Stephen J Quinn; Jane Phillips; Caroline Litster; Natasha Michael; Matthew Doogue; Debra Rowett; David C Currow
Journal:  J Palliat Med       Date:  2013-10-18       Impact factor: 2.947
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.